Drug Shortage Report for ROFACT
Report ID | 222584 |
Drug Identification Number | 00343617 |
Brand name | ROFACT |
Common or Proper name | ROFACT |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | RIFAMPIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100's |
ATC code | J04AB |
ATC description | DRUGS FOR TREATMENT OF TUBERCULOSIS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2024-03-18 |
Estimated end date | 2024-04-17 |
Actual end date | 2024-04-16 |
Shortage status | Resolved |
Updated date | 2024-04-17 |
Company comments | Delays in testing at external lab |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2024-04-17 | French | Compare |
v9 | 2024-04-17 | English | Compare |
v8 | 2024-04-10 | French | Compare |
v7 | 2024-04-10 | English | Compare |
v6 | 2024-04-09 | French | Compare |
v5 | 2024-04-09 | English | Compare |
v4 | 2024-03-19 | English | Compare |
v3 | 2024-03-18 | French | Compare |
v2 | 2024-03-18 | French | Compare |
v1 | 2024-03-18 | English | Compare |
Showing 1 to 10 of 10